文献速递淋巴瘤

结外NK/T细胞淋巴瘤的7-SNP复合预测标签

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
PubMed 文献 · Blood · 2021-01-01

研究基于722例接受非蒽环类方案治疗的结外NK/T细胞淋巴瘤(ENKTL)患者,用LASSO Cox回归构建7-SNP分类器并在内部和外部队列验证。该分类器可区分高低危患者的PFS和OS(均P<.001),为独立预后因素且预测准确性优于临床病理变量,并构建了列线图。

要点

  • 7-SNP分类器在训练和3个验证队列中均显示良好预后预测效能。
  • 高危与低危评分患者PFS和OS差异显著(均P<.001)。
  • 高危I期患者放化疗较单纯放疗显著改善PFS和OS,低危患者两种治疗无统计学差异。

核心结论

  • 7-SNP分类器是ENKTL现有风险分层系统的补充,可能对临床决策有重要意义。

研究设计与样本

  • 多中心回顾性分析722例ENKTL患者,训练队列n=336,内部测试队列n=144,外部验证队列n=142和n=100。
  • 采用LASSO Cox回归构建7-SNP分类器。

主要发现

  • 7-SNP分类器在训练队列和3个验证队列中均显示良好预后预测效能。
  • 高、低风险评分患者的PFS和OS差异显著(均P<.001)。
  • 多因素分析证实7-SNP分类器为独立预后因素,预测准确性显著优于临床病理风险变量。
  • 分类器的应用不受样本类型影响。
  • 在高危Ann Arbor I期患者中,化疗联合放疗较单纯放疗显著改善PFS和OS;低危患者两种治疗模式无统计学差异。

关键数值与推荐

  • 7-SNP分类器计算高、低风险评分,高低危患者PFS和OS差异均P<.001。
  • 列线图整合分类器与临床病理变量,预测准确性优于任一单独变量。

临床怎么用

  • 可用7-SNP分类器对接受非蒽环类治疗的ENKTL患者进行风险分层,辅助临床决策。
  • 高危Ann Arbor I期患者可考虑化疗联合放疗而非单纯放疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current prognostic scoring systems based on clinicopathologic variables are inadequate in predicting the survival and treatment response of extranodal natural killer/T-cell lymphoma (ENKTL) patients undergoing nonanthracyline-based treatment. We aimed to construct a classifier based on single-nucleotide polymorphisms (SNPs) for improving predictive accuracy and guiding clinical decision making. Data from 722 patients with ENKTL from international centers were analyzed. A 7-SNP-based classifier was constructed using LASSO Cox regression in the training cohort (n = 336) and further validated in the internal testing cohort (n = 144) and in 2 external validation cohorts (n = 142 and n = 100). The 7-SNP-based classifier showed good prognostic predictive efficacy in the training cohort and the 3 validation cohorts. Patients with high- and low-risk scores calculated by the classifier exhibited significantly different progression-free survival (PFS) and overall survival (OS) (all P < .001). The 7-SNP-based classifier was further proved to be an independent prognostic factor by multivariate analysis, and its predictive accuracy was significantly better than clinicopathological risk variables. Application of the 7-SNP-based classifier was not affected by sample types. Notably, chemotherapy combined with radiotherapy significantly improved PFS and OS vs radiotherapy alone in high-risk Ann Arbor stage I patients, whereas there was no statistical difference between the 2 therapeutic modalities among low-risk patients. A nomogram was constructed comprising the classifier and clinicopathological variables; it showed remarkably better predictive accuracy than either variable alone. The 7-SNP-based classifier is a complement to existing risk-stratification systems in ENKTL, which could have significant implications for clinical decision making for patients with ENKTL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Tian XP, Ma SY, Young KH, et al. A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma. Blood. 2021. PMID: 33728448. doi:10.1182/blood.2020010637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。